Those looking for a hot stock to buy should consider a flutter on Dow Global Technologies Inc. (NYSE:DOW). They have developed a new technology to ferment vaccines much quicker than traditional methods, especially important in finding vaccines for recombinant strains of virus' such as H1N1. Merck and Pfizer have both signed agreements with DowPharma for the new technology.
They also hold a patent on a vaccine filed in 2006. Their production subsidiary is Serum Institute of India Ltd., the world's largest producer of vaccines.
No comments:
Post a Comment